肝:病变发生,治疗和持续的挑战
Michelle Angeles-Solano1, Zajeba Tabashsum1, Liang Chen2
1Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
Infection and immunity
|July 3, 2025
概括
在全球范围内,高病毒性Klebsiella肺炎 (hvKp) 导致严重的肝 (KLA). 由于腹障碍和新兴的多药性耐药性,有效的治疗具有挑战性.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 病变的发生和发病.
背景情况:
- 超病毒性Klebsiella肺炎 (hvKp) 导致侵入性感染,特别是Klebsiella肝 (KLA).
- 曾经是亚洲本土的KLA,现在是一个日益严重的全球健康问题.
- hvKp从肠道传播到肝脏,K1和K2囊类型逃避免疫清除.
研究的目的:
- 审查KLA的病变发生过程.
- 突出KLA管理和治疗中的挑战.
主要方法:
- 关于KLA病原和治疗障碍的文献综述.
- 对hvKp特征和临床影响的分析.
主要成果:
- KLA的形成涉及hvKp的传播和库普弗细胞逃逸.
- 带来了治疗挑战,影响了抗生素的疗效.
- 糟糕的结果和并发症,如转移性感染可能会发生.
结论:
- hvKp构成重大威胁,KLA发病率在全球范围内不断增加.
- 对于KLA的治疗策略受到腹环境和新出现的抵抗的限制.
- 需要进一步的研究来克服治疗障碍.
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
44
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
44
Pleural Effusion II: Symptoms and Management
275
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
275
Pneumonia IV: Management
455
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
455
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
111
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
111
Pneumonia III: Complications and Assessment
452
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
452
Urinary Tract Infection II: Pathophysiology
52
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
52


